A detailed history of Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Trust CO holds 6,254 shares of GILD stock, worth $587,563. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,254
Previous 7,060 11.42%
Holding current value
$587,563
Previous $484,000 8.26%
% of portfolio
0.06%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$66.59 - $83.99 $53,671 - $67,695
-806 Reduced 11.42%
6,254 $524,000
Q2 2024

Jul 15, 2024

BUY
$63.15 - $72.88 $51,025 - $58,887
808 Added 12.92%
7,060 $484,000
Q1 2024

Apr 11, 2024

SELL
$71.58 - $87.29 $272,147 - $331,876
-3,802 Reduced 37.82%
6,252 $457,000
Q4 2023

Jan 10, 2024

BUY
$73.27 - $83.09 $32,165 - $36,476
439 Added 4.57%
10,054 $814,000
Q3 2023

Dec 04, 2023

BUY
$73.94 - $80.67 $420,496 - $458,770
5,687 Added 144.78%
9,615 $720,000
Q2 2023

Jul 10, 2023

BUY
$76.01 - $86.7 $252,581 - $288,104
3,323 Added 549.26%
3,928 $302,000
Q1 2023

Apr 07, 2023

SELL
$77.31 - $88.08 $127,793 - $145,596
-1,653 Reduced 73.21%
605 $50,000
Q4 2022

Jan 09, 2023

SELL
$62.32 - $89.47 $782,614 - $1.12 Million
-12,558 Reduced 84.76%
2,258 $194,000
Q3 2022

Oct 11, 2022

BUY
$59.54 - $68.01 $360,514 - $411,800
6,055 Added 69.11%
14,816 $914,000
Q2 2022

Jul 06, 2022

SELL
$57.72 - $65.01 $816,103 - $919,176
-14,139 Reduced 61.74%
8,761 $542,000
Q1 2022

Apr 08, 2022

BUY
$57.92 - $72.58 $193,916 - $242,997
3,348 Added 17.12%
22,900 $1.36 Million
Q4 2021

Jan 14, 2022

BUY
$64.88 - $73.64 $33,348 - $37,850
514 Added 2.7%
19,552 $1.42 Million
Q3 2021

Oct 20, 2021

SELL
$67.69 - $73.03 $65,523 - $70,693
-968 Reduced 4.84%
19,038 $1.33 Million
Q2 2021

Jul 14, 2021

SELL
$63.47 - $69.35 $2,475 - $2,704
-39 Reduced 0.19%
20,006 $1.38 Million
Q1 2021

Apr 08, 2021

BUY
$60.0 - $68.46 $357,720 - $408,158
5,962 Added 42.33%
20,045 $1.3 Million
Q4 2020

Jan 12, 2021

BUY
$56.65 - $64.55 $154,994 - $176,608
2,736 Added 24.11%
14,083 $820,000
Q3 2020

Oct 06, 2020

BUY
$62.1 - $78.08 $28,255 - $35,526
455 Added 4.18%
11,347 $717,000
Q2 2020

Jul 17, 2020

BUY
$72.34 - $84.0 $95,561 - $110,964
1,321 Added 13.8%
10,892 $838,000
Q1 2020

Apr 07, 2020

SELL
$62.63 - $80.22 $13,715 - $17,568
-219 Reduced 2.24%
9,571 $716,000
Q4 2019

Jan 07, 2020

BUY
$61.62 - $67.78 $39,560 - $43,514
642 Added 7.02%
9,790 $636,000
Q3 2019

Oct 09, 2019

SELL
$62.51 - $69.0 $166,464 - $183,747
-2,663 Reduced 22.55%
9,148 $580,000
Q2 2019

Jul 08, 2019

SELL
$61.87 - $69.38 $1.67 Million - $1.87 Million
-27,016 Reduced 69.58%
11,811 $798,000
Q1 2019

Apr 08, 2019

BUY
$62.53 - $70.05 $2.42 Million - $2.71 Million
38,747 Added 48433.75%
38,827 $2.52 Million
Q3 2018

Oct 09, 2018

SELL
$71.28 - $78.92 $11,190 - $12,390
-157 Reduced 66.24%
80 $6,000
Q2 2018

Jul 10, 2018

SELL
$64.88 - $75.68 $483,875 - $564,421
-7,458 Reduced 96.92%
237 $17,000
Q1 2018

Apr 09, 2018

SELL
$72.84 - $88.8 $5.5 Million - $6.7 Million
-75,466 Reduced 90.75%
7,695 $580,000
Q4 2017

Jan 11, 2018

BUY
$71.15 - $83.52 $491,148 - $576,538
6,903 Added 9.05%
83,161 $5.96 Million
Q3 2017

Oct 12, 2017

BUY
$72.11 - $85.47 $5.5 Million - $6.52 Million
76,258
76,258 $6.18 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Trust CO Portfolio

Follow Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO with notifications on news.